Fortrea Executive and Leadership Team

Mark Morais, the Clinical Services Chief Operating Officer & President at Fortrea, oversees the execution of complex clinical trials across diverse therapeutic areas. Directing large-scale operational teams, the Clinical Services Chief Operating Officer & President ensures adherence to global regulatory standards while driving efficiency in research and development services. This leadership position involves coordinating cross-functional departments to deliver high-quality data for biotechnology and pharmaceutical partners. By refining trial management processes, Mark Morais optimizes resource allocation and project timelines on a global scale. The Clinical Services Chief Operating Officer & President maintains constant communication with the Board to report on operational performance and strategic milestones. Through the implementation of innovative problem-solving methodologies, the Clinical Services Chief Operating Officer & President enhances the company's ability to navigate the complexities of modern drug development, ensuring that promising medical ideas reach patients with speed and precision.

Oren Cohen, the Chief Medical Officer and President, Clinical Pharmacology Services at Fortrea, leads the scientific strategy and clinical pharmacology initiatives. Directing medical oversight for complex trials, the Chief Medical Officer and President, Clinical Pharmacology Services ensures that all research activities meet the highest standards of safety and efficacy. This role involves guiding the development of innovative therapies by applying deep scientific expertise to the clinical development process. By supervising medical teams across global research facilities, Oren Cohen maintains the company's reputation for scientific rigor. The Chief Medical Officer and President, Clinical Pharmacology Services interacts frequently with regulatory bodies and client stakeholders to ensure alignment on trial design and data interpretation. Through the application of advanced pharmacological insights, the Chief Medical Officer and President, Clinical Pharmacology Services accelerates the transition of medical concepts into proven therapies, directly impacting the success of biotechnology and pharmaceutical clients worldwide.

Ding Ming, the Fortrea President & General Manager (China) at Fortrea, directs all clinical research operations and business development within the Chinese market. Overseeing regional expansion and local partnerships, the Fortrea President & General Manager (China) ensures that the company's global clinical research solutions adapt effectively to the unique regulatory and healthcare landscape of the region. This role involves managing specialized teams to deliver high-quality research services for local and international pharmaceutical clients. By driving growth in the Asia Pacific market, Ding Ming strengthens the company's global network and operational reach. The Fortrea President & General Manager (China) collaborates with corporate leadership to integrate regional insights into the broader organizational strategy. Through the execution of localized clinical development plans, the Fortrea President & General Manager (China) enhances the company's competitive position, ensuring that innovative medical ideas receive the necessary support to advance through the clinical trial process efficiently.

Madeshwaran Rajendran, the Chief Information Officer, Information Technology Vendor Management-Office at Fortrea, directs the digital architecture supporting global clinical research. Managing complex vendor ecosystems, the Chief Information Officer, Information Technology Vendor Management-Office ensures seamless integration of data systems across North America and international research sites. This role involves optimizing technology stacks to maintain scientific rigor while accelerating development timelines for pharmaceutical clients. By streamlining IT procurement and vendor performance, Madeshwaran Rajendran strengthens the technological foundation necessary for high-stakes clinical trials. The Chief Information Officer, Information Technology Vendor Management-Office also collaborates with executive leadership to align digital transformation initiatives with long-term corporate growth objectives. Through constant monitoring of cybersecurity protocols and infrastructure scalability, the Chief Information Officer, Information Technology Vendor Management-Office guarantees operational continuity across all global facilities, ultimately securing the integrity of sensitive research data throughout the entire clinical development lifecycle.

David Cooper, the Chief Administrative Officer at Fortrea, manages the internal corporate functions that sustain global clinical research operations. Overseeing human resources, facilities management, and organizational development, the Chief Administrative Officer ensures that specialized teams possess the necessary infrastructure to perform high-level research. This role involves aligning administrative policies with the company's mission to provide comprehensive clinical research solutions. By fostering a culture of operational excellence, David Cooper supports the broader business model across North America, Europe, and Asia Pacific. The Chief Administrative Officer collaborates with other C-suite leaders to streamline internal processes, thereby reducing overhead and increasing organizational agility. Through the strategic management of corporate assets and personnel, the Chief Administrative Officer drives efficiency and maintains the high standards of scientific rigor required by the pharmaceutical and healthcare industries, ultimately contributing to the long-term stability and growth of the entire organization.